Zhou Zhen-Fa, Hu Cui-Fen, Gao Mei-Fang, Jin Xian, Chen Yu, Wang Di, Shen Cheng-Xing, Liu Liang
Department of Cardiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Department of Ultrasound in Medicine, Minhang Hospital, Fudan University, Shanghai, China.
J Thorac Dis. 2024 Aug 31;16(8):5073-5085. doi: 10.21037/jtd-24-204. Epub 2024 Aug 12.
Acute myocardial infarction (AMI) is the most severe manifestation of coronary heart disease (CHD), and timely and effective opening of the culprit vessels has been effective in reducing its mortality, but long-term death still threatens the life of patients. Therefore, finding biomarkers to predict death post-myocardial infarction (MI) is crucial. The aim of our study is to find biomarkers that predicted long-term death in Chinese AMI patients.
This retrospective analysis included patients with AMI from 1 January 2017 to 30 September 2019. All patients were followed up at least 4 years. Propensity score matching was used to mitigate the influence of nonrandom selection in MI-survival and MI-death groups. Cox analysis was applied for analyzing the risk factors of death post-MI. The receiver operating characteristic (ROC) curve was used to analyze the predictive value of biomarkers.
Of the 1,059 AMI patients analyzed, 130 died during follow-up. After propensity matching, there were 116 patients in each of the two groups. In addition to the traditional risk factors for long-term death post-MI, two important risk factors platelet distribution width (PDW) [hazard ratio (HR) =1.210, 95% confidence interval (CI): 1.080-1.356, P=0.001] and fibrinogen (HR =1.218, 95% CI: 1.027-1.444, P=0.02) were found. The area under the curve (AUC) of PDW and fibrinogen was 0.604 (P=0.007) and 0.684 (P<0.001) respectively. The optimal thresholds were 13.05% and 3.562 g/L respectively.
PDW and fibrinogen seem to be useful as biomarkers for long-term death prediction post-MI. The current research provides new insight into the prevention and treatment of death in Chinese patients post-MI.
急性心肌梗死(AMI)是冠心病(CHD)最严重的表现形式,及时有效地开通罪犯血管已有效降低其死亡率,但长期死亡仍威胁着患者生命。因此,寻找预测心肌梗死(MI)后死亡的生物标志物至关重要。本研究的目的是寻找预测中国AMI患者长期死亡的生物标志物。
本回顾性分析纳入了2017年1月1日至2019年9月30日期间的AMI患者。所有患者均进行了至少4年的随访。采用倾向评分匹配来减轻MI存活组和MI死亡组中非随机选择的影响。应用Cox分析来分析MI后死亡的危险因素。采用受试者工作特征(ROC)曲线来分析生物标志物的预测价值。
在分析的1059例AMI患者中,130例在随访期间死亡。倾向匹配后,两组各有116例患者。除了MI后长期死亡的传统危险因素外,还发现了两个重要危险因素,即血小板分布宽度(PDW)[风险比(HR)=1.210,95%置信区间(CI):1.080-1.356,P=0.001]和纤维蛋白原(HR =1.218,95%CI:1.027-1.444,P=0.02)。PDW和纤维蛋白原的曲线下面积(AUC)分别为0.604(P=0.007)和0.684(P<0.001)。最佳阈值分别为13.05%和3.562 g/L。
PDW和纤维蛋白原似乎可作为预测MI后长期死亡的生物标志物。本研究为中国MI患者死亡的防治提供了新的见解。